Goal: Our newsletter aims at providing regular updates on the science and the truth behind the current pandemic. We are dedicated to bringing the real science to the table and sharing how the truth invalidates the current narrative, for which scientific evidence is now increasingly lacking. We’ll provide an update on a (semi-)weekly basis, on Mondays and/or Fridays. We sincerely hope this newsletter will contribute to raising awareness about the consequences of human intervention in this pandemic, particularly of mass vaccination, from both an individual and public health perspective.
“Lack of understanding of immunology and the impact of non-neutralizing Abs on the infectious and pathogenic behavior of SARS-CoV-2 leads our health authorities to erroneous and very dangerous conclusions in that they consider re-vaccination of C-19 vaccinees with an updated S(Omicron)-based C-19 vaccine, for example, a promising avenue to control the pandemic whereas this is only going to precipitate the emergence of SARS-CoV-2 variants that combine high infectiousness in vaccinees with high virulence and full resistance to foreign-centered C-19 vaccines.”
“Dovaccinated people shed their vaccine byproducts to us? We definitely,for sure, knew that vaccine shedding was not a thing, because “healthexperts and fact checkers” told us so. And we “believe science”and our “health experts”. Right?”
“Finally, as an obvious but overlooked suggestion, the government should also be encouraging the population to take safe and affordable steps to boost their immune systems naturally, such as getting out in the sunlight to raise vitamin D levels and eating mainly organic whole foods rather than chemical-laden processed foods. Also, eating foods that are good sources of vitamin A, vitamin C and vitamin K2 should be encouraged, as deficiencies in these vitamins are linked to poor outcomes from COVID-19.”
“Some of the state’s highest transmission rates are now being recorded int he San Francisco Bay Area. San Francisco now has the highest daily case rate at 32 per 100,000, a 66% increase compared to two weeks earlier.”
“All that said, I’m glad Gates put pen to paper. Just like finding yourself sitting at a bar with a crazy person, such an experience can be very interesting, provided the drinks are flowing and he is picking up the tab. Just don’t put them in charge of anything.Otherwise, we will in fact lose all voice in public affairs, exactly as Gates seems to desire.”
“This area continues to be about the only CONUS cases hotspot going (apart from what seems to be some border crossing issues in TX) and it’s flowing into the hospitals. but it’s, for the most part, only affecting the old. and the pattern looks the same pretty much everywhere”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.